Cytokinetics (NASDAQ: CYTK)
Cytokinetics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cytokinetics Company Info
Cytokinetics is a biopharmaceutical company focused on developing small-molecule therapeutics for the treatment of cardiovascular diseases and cancer.
News & Analysis
Why Cytokinetics Stock Was a Nearly 5% Winner Today
2 Incredible Growth Stocks to Buy Right Now
These two biotech stocks could be big winners in the years ahead.
Here's Why Cytokinetics Is Rocketing Higher Today
The company's new heart drug candidate produced encouraging clinical trial results.
Here's Why Cytokinetics Is Skyrocketing 24.5% Today
The Food and Drug Administration is fast-tracking the biotech's lead drug candidate.
Here's Why Cytokinetics Stock Tanked on Thursday
News of a public debt offering didn't go over well with investors.
Here's Why Cytokinetics Stock Jumped Today
The clinical-stage biotech's long-running partnership with Amgen took another big step forward.
Why Cytokinetics, Inc. Jumped Higher Today
The biotech will join the S&P SmallCap 600 index.
Why Cytokinetics, Inc. Got Hammered Today
What the biotech didn't say might have caused its downfall.
Valuation
Earnings Transcripts
Cytokinetics, Incorporated (CYTK) Q3 2021 Earnings Call Transcript
CYTK earnings call for the period ending September 30, 2021.
Cytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript
CYTK earnings call for the period ending June 30, 2021.
Cytokinetics Inc (CYTK) Q1 2021 Earnings Call Transcript
CYTK earnings call for the period ending March 31, 2021.
Cytokinetics Inc (CYTK) Q4 2020 Earnings Call Transcript
CYTK earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.